(Q44070457)

29 November 2017

title

Ex vivo localization of the mouse saposin C activation region for acid beta-glucosidase (English)

1 reference

29 November 2017

Xiaoyang Qi

1

1 reference

29 November 2017

Keiji Kondoh

2

1 reference

29 November 2017

Hulian Yin

3

1 reference

29 November 2017

Mei Wang

4

1 reference

29 November 2017

Elvira Ponce

5

1 reference

29 November 2017

Ying Sun

6

1 reference

29 November 2017

Gregory A Grabowski

7

1 reference

29 November 2017

publication date

1 July 2002

1 reference

Molecular Genetics and Metabolism

29 November 2017

published in

1 reference

29 November 2017

volume

76

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

189-200

1 reference

Proteolytic processing patterns of prosaposin in insect and mammalian cells

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Biosynthesis, processing, and targeting of sphingolipid activator protein (SAP )precursor in cultured human fibroblasts. Mannose 6-phosphate receptor-independent endocytosis of SAP precursor

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Immunological evidence for deficiency in an activator protein for sulfatide sulfatase in a variant form of metachromatic leukodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

The mechanism for a 33-nucleotide insertion in mRNA causing sphingolipid activator protein (SAP-1)-deficient metachromatic leukodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Identification of the neurotrophic factor sequence of prosaposin

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Functional organization of saposin C. Definition of the neurotrophic and acid beta-glucosidase activation regions

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Prosaposin facilitates sciatic nerve regeneration in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

A hydrophilic peptide comprising 18 amino acid residues of the prosaposin sequence has neurotrophic activity in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Conformational and amino acid residue requirements for the saposin C neuritogenic effect

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Saposin A: second cerebrosidase activator protein

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Turnover and distribution of intravenously administered mannose-terminated human acid beta-glucosidase in murine and human tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Synthesis, spectral properties and enzymatic hydrolysis of fluorescent derivatives of cerebroside sulfate containing long-wavelength-emission probes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Cultured oligodendrocytes metabolize a fluorescent analogue of sulphatide; inhibition by monensin

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Intracellular degradation of fluorescent glycolipids by lysosomal enzymes and their activators

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

Differential membrane interactions of saposins A and C: implications for the functional specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900040-9

7 January 2021

10.1016/S1096-7192(02)00040-9

Identifiers

DOI

1 reference

29 November 2017

1 reference